Cellectar Biosciences, Inc. (CLRB) at a glance

Cellectar Biosciences, Inc. (CLRB) is a micro-cap Healthcare company. It trades at $2.54, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 51/100 overall. Its strongest dimension is Safety (70/100) and its weakest is Momentum (18/100). It is a relatively defensive holding with below-market volatility.

Price

$2.54

Market cap

$24.0M

P/E ratio

n/a

Dividend yield

None

Beta

0.56

52-week range

$2.20 to $6.52